Published September 3, 2010 | Version v1
Journal article

Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis

  • 1. State Key Laboratory of Cancer Biology, Department of Gastrointestinal Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an (China)
  • 2. Department of Anorectal Surgery, Tianjin Union Medicine Centre, Tianjin (China)
  • 3. Department of Urology Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an (China)
  • 4. Department of Health Statistics, The Fourth Military Medical University, Xi'an (China)
  • 5. Department of Vascular and Endocrine Surgery, Xijing Hospital, The Fourth Military Medical University, Xi'an (China)

Description

The cytokine-induced anti-apoptotic molecule (CIAPIN1) had been found to be a differentially-expressed gene involved in a variety of cancers, and it was also considered as a candidate tumour suppressor gene in gastric cancer, renal cancer and liver cancer. However, studies on the role of CIAPIN1 in colorectal cancer were still unavailable. The aim of this study was to determine the prognostic impact of CIAPIN1 in 273 colorectal cancer (CRC) samples and to investigate the CIAPIN1 expression in CRC cell lines after inducing differentiation. Immunohistochemical analysis was performed to detect the expression of CIAPIN1 in CRC samples from 273 patients. The relationship between CIAPIN1 expression and patients' characteristics (gender, age, location of cancer, UICC stage, local recurrence and tumour grade factors) was evaluated. In addition, these patients were followed up for five consecutive years to investigate the relationship between CIAPIN1 expression and the prognosis of CRC. We induced the differentiation of the CRC cell lines HT29 and SW480, in order to detect the expression of CIAPIN1 in the process of CRC cells differentiation. Results indicated that CIAPIN1 was mainly expressed in the cytoplasm and nucleus, and that its expression level in cancer samples was significantly lower than in normal tissues. The Wilcoxon-Mann-Whitney test showed a significant difference in the differential expression of CIAPIN1 in patients with different T and UICC stages, and tumour grade (P = 0.0393, 0.0297 and 0.0397, respectively). The Kaplan-Meier survival analysis demonstrated that the survival time of CRC patients with high expression of CIAPIN1 was longer than those with low expression during the 5-year follow up period (P = 0.0002). COX regression analysis indicated that low expression of CIAPIN1, cancer stage of > pT1, distant organ metastasis (pM1), regional lymph node metastasis (> pN1) and local recurrence (yes) were independent, poor prognostic factors of CRC (P = 0.012, P = 0.032, P <0.001, P <0.001, P <0.001 respectively). Both Western blotting and RT-PCR showed that CIAPIN1 expression was increased with the degree of differentiation of HT29 and SW480 cells. CIAPIN1 played an important role in the differentiation of CRC cells, and the differential expression of CIAPIN1 in CRC was closely related to prognosis

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-10-477; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944177

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
10
Journal Page Range
p. 477
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46098639
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CORRELATIONS; CYTOPLASM; GENES; LIVER; LYMPH NODES; NEOPLASMS; PATIENTS; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SURVIVAL TIME
Descriptors DEC
BODY; CELL CONSTITUENTS; DIGESTIVE SYSTEM; DISEASES; GENE AMPLIFICATION; GLANDS; LYMPHATIC SYSTEM; MATHEMATICS; ORGANS; STATISTICS

Optional Information

Copyright
Copyright (c)2010 Shi et al
Notes
PMCID: PMC2944177; PUBLISHER-ID: 1471-2407-10-477; PMID: 20815902; OAI: oai:pubmedcentral.nih.gov:2944177; licensee BioMed Central Ltd.